Dr. Elizabeth Grace Munro, MD

Dr. Munro practices at OHSU Hospital in Portland, Oregon, part of State of Oregon.

Dr. Munro's NPI, 1508838897, was assigned on February 2, 2006. Dr. Munro graduated from Columbia University College of Physicians and Surgeons in 2002. Dr. Munro holds Oregon license MD29435.

Dr. Munro's primary practice is OHSU Hospital, at 3181 SW Sam Jackson Park Road, Portland, OR 97239 in Multnomah County. The practice phone is (503) 494-9000.

Dr. Munro's primary practice is OHSU Hospital in Portland, Oregon, part of State of Oregon. Dr. Munro is also affiliated with Salem Hospital. The medical group on file is Oregon Health & Science University (OHSU). Dmand AI also links Dr. Munro to 1 more hospital, 1 clinical lab and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Munro practices, 4 sites in all. Vendor and product names are available with a free account.

Gynecologic oncology is Dr. Munro's primary specialty in the NPI Registry, under taxonomy code 207VX0201X. Dmand AI has Dr. Munro's licenses on file in 3 states: Oregon, Massachusetts and New Hampshire.

CMS data shows 294 Medicare services from Dr. Munro across 3 procedure codes in 2024, for 94 Medicare patients. Medicare paid $11,887 for them.

CMS counts 94 Medicare patients who saw Dr. Munro in 2024. The largest group is 65 to 74, with 43 patients. 56% of them have high blood pressure, and 55% have cancer. 20% are also on Medicaid. Their average risk score is 1.67, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Munro's median patient age at 67, with 98% women.

In 2024, Dr. Munro wrote 241 Medicare Part D claims for 51 patients. 85% of them were for generic drugs. CMS names the drug for 83 of them, across 4 drugs with 11 or more claims each, at $1,126 in total drug cost. In 2023, CMS named 43 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 99 out of 100 for Dr. Munro for performance year 2024, reported through an alternative payment model (APM). Dr. Munro accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Munro as offering telehealth.

Colonoscopy: 1 to 10 procedures (CMS shows small counts as a range)

Hernia repair - groin (open): 1 to 10 procedures (CMS shows small counts as a range)

Removal of the uterus: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 13 papers to Dr. Munro, published from 2011 to 2023. 2021 was the busiest year, with 3. The most frequent topics are Cost-Benefit Analysis, Ovarian Neoplasms and Uterine Cervical Neoplasms. Dr. Munro has published most often in Gynecol Oncol. Dr. Munro's most frequent co-authors are Samantha Batman, MD, Jaime Michelle Kiff, MD and Jacqueline Bohn, MD.

Dmand AI links Dr. Munro to 2 clinical trials. 1 is still active or recruiting. Conditions studied include Fallopian Tube Diseases, Glioblastoma and Astrocytoma.

CMS Open Payments shows 18 general payments to Dr. Munro from 4 drug and device companies from 2019 to 2025. Speaker and faculty fees make up the largest share, 70% of the total. Corcept Therapeutics paid the most, $6,553.

Dr. Munro graduated from Columbia University College of Physicians and Surgeons in 2002.